“A lot of the great breakthroughs in America have come from people that immigrated,” said the Swedish Jewish doctor turned pharmaceutical industry leader. (JTA) — When Mikael Dolsten, the ...

Citing people familiar with the matter, The Journal reported that Starboard approached former Pfizer CEO Ian Read and CFO ...

Pfizer’s chief scientific officer and president of R&D, Mikael Dolsten, has said he will step down from the role in the coming months, kicking off the search for a successor. Dolsten’s ...

Dr. Dolsten is an accomplished industry executive with extensive global pharmaceutical management experience. "As an industry-leading pharmaceutical executive, I am very pleased to welcome Mikael ...

US pharmaceutical giant Pfizer on Tuesday said its chief scientific officer Mikael Dolsten, a key figure behind the ...

During the Q2 earnings call, we found out that Mikael Dolsten, the Chief Scientific Officer and President of Pfizer Research & Development, will be departing the company. As it was noted ...

“Rocket has an impressive pipeline of clinical programs which have shown tremendous promise potentially curing genetic disease,” said Dr. Mikael Dolsten, Chief Scientific Officer and ...

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today ...

Dr. Dolsten is an accomplished industry executive with extensive global pharmaceutical management experience. "As an industry-leading pharmaceutical executive, I am very pleased to welcome Mikael to ...